Scopus Asset Management, L.P. Synthetic Biologics, Inc. Call Options Transaction History

Scopus Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$2.9 - $4.6 $652,500 - $1.03 Million	-225,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.4 - $80.5 $4.59 Million - $18.1 Million	225,000 New	225,000 $585,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Scopus Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Scopus Asset Management, L.P. with notifications on news.